Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor


Haemagglutinin and neuraminidase surface glycoproteins of the bat influenza H17N10 virus neither bind to nor cleave sialic acid receptors, indicating that this virus employs cell entry mechanisms distinct from those of classical influenza A viruses. We observed that certain human haematopoietic cancer cell lines and canine MDCK II cells are susceptible to H17-pseudotyped viruses. We identified the human HLA-DR receptor as an entry mediator for H17 pseudotypes, suggesting that H17N10 possesses zoonotic potential.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: The H17N10 cellular receptor(s) is not ubiquitous and is proteinaceous.
Fig. 2: Surface expression of HLA-DR is a key determinant for entry of H17 pseudotypes into mammalian cells.

Data availability

Microarray data are available at the Gene Expression Omnibus (GEO) repository under the series record number GSE14837. All other data supporting the findings of this study are available from the corresponding author on request.


  1. 1.

    Tong, S. et al. Proc. Natl Acad. Sci. USA 109, 4269–4274 (2012).

    CAS  Article  Google Scholar 

  2. 2.

    Tong, S. et al. PLoS Pathog. 9, e1003657 (2013).

    Article  Google Scholar 

  3. 3.

    Ciminski, K. et al. J. Gen. Virol. 98, 2393–2400 (2017).

    CAS  Article  Google Scholar 

  4. 4.

    Long, J. S., Mistry, B., Haslam, S. M. & Barclay, W. S. Nat. Rev. Microbiol. 17, 67–81 (2019).

    CAS  Article  Google Scholar 

  5. 5.

    Sun, X. et al. Cell Rep. 3, 769–778 (2013).

    CAS  Article  Google Scholar 

  6. 6.

    Zhu, X. et al. Proc. Natl Acad. Sci. USA 109, 18903–18908 (2012).

    CAS  Article  Google Scholar 

  7. 7.

    Juozapaitis, M. et al. Nat. Commun. 5, 4448 (2014).

    CAS  Article  Google Scholar 

  8. 8.

    Wu, Y. et al. Trends Microbiol. 22, 183–191 (2014).

    CAS  Article  Google Scholar 

  9. 9.

    Maruyama, J. et al. Virology 488, 43–50 (2016).

    CAS  Article  Google Scholar 

  10. 10.

    Moreira, E. A. et al. Proc. Natl Acad. Sci. USA 113, 12797–12802 (2016).

    CAS  Article  Google Scholar 

  11. 11.

    Hoffmann, M. et al. PLoS ONE 11, e0152134 (2016).

    Article  Google Scholar 

  12. 12.

    Carnell, G. W. et al. Front. Immunol. 6, 161 (2015).

    Article  Google Scholar 

  13. 13.

    Carnell, G. et al. Preprint at (2018).

  14. 14.

    Dukes, J. D. et al. BMC Cell Biol. 12, 43 (2011).

    CAS  Article  Google Scholar 

  15. 15.

    Roche, P. A. et al. Nat. Rev. Immunol. 15, 203–216 (2015).

    CAS  Article  Google Scholar 

  16. 16.

    Ziegler, A. et al. Immunobiology 171, 77–92 (1986).

    CAS  Article  Google Scholar 

  17. 17.

    Karakus, U. et al. Nature 567, 109–112 (2019).

    CAS  Article  Google Scholar 

  18. 18.

    de Vries, E. et al. Proc. Natl Acad. Sci. USA 109, 7457–7462 (2012).

    Article  Google Scholar 

  19. 19.

    Giotis, E. S. et al. Sci. Rep. 7, 17485 (2017).

    CAS  Article  Google Scholar 

  20. 20.

    Kall, L. et al. Nucleic Acids Res. 35, W429–W432 (2007).

    Article  Google Scholar 

  21. 21.

    Krogh, A. et al. J. Mol. Biol. 305, 567–580 (2001).

    CAS  Article  Google Scholar 

  22. 22.

    Almagro-Armenteros, J. J. et al. Bioinformatics 33, 4049 (2017).

    Article  Google Scholar 

Download references


We thank J. Kaufman, Y. Guo, I. Elbusifi, D. Quinn, A. Ho, K. Ciminski and M. Schwemmle for their support. Cells were kindly provided by E. Wright (University of Sussex, Falmer, UK), K. Paschos, R. White, M. Dorner, M. Edwards, P. Farrell and R. Shattock (Imperial College London, London, UK). This research was undertaken with the financial support of the Biotechnology and Biological Sciences Research Council (BBSRC) ( via the Strategic LoLa grant BB/K002465/1 ‘Developing Rapid Responses to Emerging Virus Infections of Poultry (DRREVIP)’ and the Octoberwoman Foundation. L.-F.W. is supported by the Singapore National Research Foundation grants (NRF2012NRF-CRP001-056 and NRF2016NRF-NSFC002-013).

Author information




E.S.G. conceived, designed and performed the experiments, analysed the data and wrote the manuscript. G.C. generated the luciferase reporter plasmids, produced the pseudotype viral stocks and wrote the manuscript. E.F.Y., S.G. and P.S. performed the microarray work. W.S.B., M.A.S. and N.T. designed the experiments and wrote the manuscript. L.-F.W. provided materials and engaged in discussion of the project.

Corresponding author

Correspondence to Efstathios S. Giotis.

Ethics declarations

Ethics statement

The buffy coat residues for the isolation of CD19+ primary B cells were purchased from the UK Blood Transfusion Service from anonymous volunteer blood donors. Therefore, no ethical approval is required.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Supplementary Discussion, Supplementary Tables 1 and 2, Supplementary Figs. 1–7 and Supplementary References.

Reporting Summary

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Giotis, E.S., Carnell, G., Young, E.F. et al. Entry of the bat influenza H17N10 virus into mammalian cells is enabled by the MHC class II HLA-DR receptor. Nat Microbiol 4, 2035–2038 (2019).

Download citation


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing